Research Library

Drug companies that bypass distributors and offer generics directly to patients, like the Mark Cuban Cost Plus Drug Company, could disrupt the pharmaceutical supply chain and ultimately save thousands of lives.

To better reflect the iterative collaboration necessary for scientific progress, the Nobel Prize must expand its recognition to the many contributors of winning discoveries as well as diversify the selection committee, thereby also expanding recognition of the work of underrepresented minorities, argues this Baker Institute Blog post.

Coronavirus cases in Texas may grow as the state expands COVID-19 screening and the consequences of delayed decisions to limit public interactions set in. "No one should be surprised lim or panic as the figures roll out," write the authors in the Baker Institute Blog.

In the second of a series of blogs on the coronovirus outbreak, the authors sound a note of cautious optimism: "We hope for a relatively optimistic outlook for the COVID-19 pandemic in the United States, with the quick realization of all modifying interventions: earlier and broader testing, strict preventive hygienic and societal measures, a safe and effective vaccine, and effective therapies to treat the virus."  Read more at the Baker Institute Blog.

The COVID-19 outbreak has now reached pandemic proportions, threatening the health of millions worldwide and adversely affecting the international economy. Understanding the status of COVID-19, its potential impact in the U.S., and the needed preventive measures could save many lives.

Despite internal changes in how scientists are nominated for the Nobel Prize, there is still a substantial gender bias in prize recipients. Concrete policy changes are needed to ensure more diversity is reflected in the world’s most visible and prestigious scientific honor, write experts Kenneth M. Evans, Kirstin R.W. Matthews and Daniel Moralí. Baker Institute blog: http://bit.ly/2MDRDbW